Fig. 2From: Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancerDose-escalation in phase I part of SNOW regimen. In part of phase I study, escalated dose of nab-paclitaxel (100–175 mg/m2 on days 1 and 15), fixed dose of oxaliplatin (65 mg/ m2 on days 1 and 15) and S-1 (80 mg/m2/day on days 1–14) are administeredBack to article page